✦ LIBER ✦

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy

✍ Scribed by Camp, E R; Wang, C; Little, E C; Watson, P M; Pirollo, K F; Rait, A; Cole, D J; Chang, E H; Watson, D K

Book ID: 120426132
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 402 KB
Volume: 20
Category: Article
ISSN: 0929-1903
DOI: 10.1038/cgt.2013.9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transferrin Receptor Targeting Nanomedic

Transferrin Receptor Targeting Nanomedicine Delivering Wild Type P53 Gene Sensitizes Pancreatic Cancer to Gemcitabine Therapy

✍ Camp, E.R.; Wang, C.; Watson, P.; Little, E.; Pirollo, K.F.; Rait, A.; Cole, D.J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Drug-resistant human bladder-cancer cell

Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells

✍ Toshiro Shirakawa; Ryohei Sasaki; Thomas A. Gardner; Chinghai Kao; Zhu-Jun Zhang 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB

We investigated the therapeutic potential and molecular mechanism of adenovirus-mediated wt p53 gene therapy for drug-resistant human bladder cancers. KK47, a human bladder-cancer cell line, along with the drug-resistant sublines KK47/DDP10, KK47/DDP20 (cisplatin-resistant) and KK47/ ADM (doxorubici